Ligand Pharmaceuticals IncorporatedLGNDNASDAQ
LOADING
|||
Cash Flow Performance
Trending higher, above historical average, strong compound growth.
Left:
||||
Free cash flow yield
Latest
3.95%
↑ 31% above average
Average (9y)
3.01%
Historical baseline
Range
High:10.64%
Low:-1.61%
CAGR
+11.9%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | 3.95% | +1242.2% |
| 2023 | -0.35% | -103.2% |
| 2022 | 10.64% | +290.4% |
| 2021 | 2.73% | -12.4% |
| 2020 | 3.11% | +293.5% |
| 2019 | -1.61% | -128.8% |
| 2018 | 5.58% | +86.1% |
| 2017 | 3.00% | +83.1% |
| 2016 | 1.64% | +13.9% |
| 2015 | 1.44% | - |